For: | Li BH, Zhao P, Liu SZ, Yu YM, Han M, Wen JK. Matrix metalloproteinase-2 and tissue inhibitor of metallo-proteinase-2 in colorectal carcinoma invasion and metastasis. World J Gastroenterol 2005; 11(20): 3046-3050 [PMID: 15918187 DOI: 10.3748/wjg.v11.i20.3046] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i20/3046.htm |
Number | Citing Articles |
1 |
Ponnuraj Nagendraprabhu, Ganapasam Sudhandiran. Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2. Investigational New Drugs 2011; 29(2): 207 doi: 10.1007/s10637-009-9342-5
|
2 |
Eun Jung Ahn, Soon Sup Chung, Ryung-Ah Lee, Kwang-Ho Kim. The Expression and Clinical Correlations of Matrix Metalloproteinase-2, -7, -9, and -12 in Colorectal Cancer. Journal of the Korean Society of Coloproctology 2009; 25(1): 26 doi: 10.3393/jksc.2009.25.1.26
|
3 |
Seweryn Gałecki, Patrycja Niesłoń, Daria Kostka, Karol Mierzwa, Magdalena Wȩgrzyn, Daniel Fochtman, Małgorzata Adamiec, Dorota Hudy, Magdalena Skonieczna. Innovations and Developments of Technologies in Medicine, Biology and Healthcare. Advances in Intelligent Systems and Computing 2022; 1360: 26 doi: 10.1007/978-3-030-88976-0_4
|
4 |
Marwan Emara, Po-Yin Cheung, Krzysztof Grabowski, Grzegorz Sawicki, Mietek Wozniak. Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers. Clinical Chemistry and Laboratory Medicine 2009; 47(8) doi: 10.1515/CCLM.2009.212
|
5 |
Magdalena Groblewska, Barbara Mroczko, Mariusz Gryko, Bogusław Kędra, Maciej Szmitkowski. Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients.. Folia Histochemica et Cytobiologica 2011; 48(4) doi: 10.2478/v10042-010-0076-1
|
6 |
John C.T. Wong, Simon K. Chan, David F. Schaeffer, Xavier Sagaert, Howard J. Lim, Hagen Kennecke, David A. Owen, Kwang W. Suh, Young-Bae Kim, Isabella T. Tai. Absence of MMP2 Expression Correlates with Poor Clinical Outcomes in Rectal Cancer, and Is Distinct from MMP1-Related Outcomes in Colon Cancer. Clinical Cancer Research 2011; 17(12): 4167 doi: 10.1158/1078-0432.CCR-10-1224
|
7 |
Xin Zhao, Xia Feng, Cun Wang, Deguang Peng, Kai Zhu, Jia-Le Song. Anticancer activity of Nelumbo nucifera stamen extract in human colon cancer HCT-116 cells in vitro. Oncology Letters 2017; 13(3): 1470 doi: 10.3892/ol.2016.5547
|
8 |
Stefaan Mulier, Yicheng Ni, Jacques Jamart, Luc Michel, Guy Marchal, Theo Ruers. Radiofrequency Ablation Versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial?. Annals of Surgical Oncology 2008; 15(1): 144 doi: 10.1245/s10434-007-9478-5
|
9 |
Thais Peretti, Jaques Waisberg, Ana Maria A. A. Mader, Leandro L. de Matos, Ricardo B. da Costa, Gleice Margarete de S. Conceição, Antônio Carlos Lopes, Helena B. Nader, Maria Aparecida S. Pinhal. Heparanase-2, syndecan-1, and extracellular matrix remodeling in colorectal carcinoma. European Journal of Gastroenterology & Hepatology 2008; 20(8): 756 doi: 10.1097/MEG.0b013e3282fc2649
|
10 |
Jing-Chun Qin, Wei-Tao Yu, Hui-Xuan Li, Yu-Qi Liang, Fei-Fei Nong, Bin Wen. Cold exposure and capsaicin promote 1,2-dimethylhyrazine-induced colon carcinogenesis in rats correlates with extracellular matrix remodeling. World Journal of Gastroenterology 2021; 27(39): 6615-6630 doi: 10.3748/wjg.v27.i39.6615
|
11 |
Thao Phuong Bui, Anh Ngoc Hoang, Phuong Lan Le, Bich Thi Pham, Linh Thi Tu Nguyen, Ha Minh Do, To Van Ta, Thai Hong Trinh. Matrix metalloproteinases in Vietnamese patients with colorectal cancer. Oncology Letters 2017; 13(4): 2097 doi: 10.3892/ol.2017.5680
|
12 |
Xian Xiao, Xiaofang Sun, Pengwen Ni, Yao Huang, Ting Xie. Phosphaturic mesenchymal tumor and related wound problem. Medicine 2018; 97(40): e12507 doi: 10.1097/MD.0000000000012507
|
13 |
Moo-Jun Baek. Prognostic Role of MMPs in Colorectal Cancer. Journal of the Korean Society of Coloproctology 2011; 27(3): 105 doi: 10.3393/jksc.2011.27.3.105
|
14 |
Charles E Patek, Mark J Arends, Lorraine Rose, Feijun Luo, Marion Walker, Paul S Devenney, Rachel L Berry, Nicola J Lawrence, Rachel A Ridgway, Owen J Sansom, Martin L Hooper. The pro-apoptotic K-Ras 4A proto-oncoprotein does not affect tumorigenesis in the Apc
Min/+mouse small intestine. BMC Gastroenterology 2008; 8(1) doi: 10.1186/1471-230X-8-24
|
15 |
Min Zhang, Yanyan Liu, Hailiang Feng, Xiaocui Bian, Wenjing Zhao, Zhenli Yang, Bei Gu, Zhanwen Li, Yuqin Liu. CD133 Affects the Invasive Ability of HCT116 Cells by Regulating TIMP-2. The American Journal of Pathology 2013; 182(2): 565 doi: 10.1016/j.ajpath.2012.10.015
|
16 |
Yueying Li, Wen Liu, Qinfeng Xu, Juan Hu, Chun-yang Zhang. Construction of a sensitive protease sensor with DNA-peptide conjugates for single-molecule detection of multiple matrix metalloproteinases. Biosensors and Bioelectronics 2020; 169: 112647 doi: 10.1016/j.bios.2020.112647
|
17 |
Xing-Xiang He, Ken Chen, Jun Yang, Xiao-Yu Li, Huo-Ye Gan, Cheng-Yong Liu, Thomas R. Coleman, Yousef Al-Abed. Macrophage Migration Inhibitory Factor Promotes Colorectal Cancer. Molecular Medicine 2009; 15(1-2): 1 doi: 10.2119/molmed.2008.00107
|
18 |
Magdalena Groblewska, Barbara Mroczko, Mariusz Gryko, Anna Pryczynicz, Katarzyna Guzińska-Ustymowicz, Bogusław Kędra, Andrzej Kemona, Maciej Szmitkowski. Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients. Tumor Biology 2014; 35(4): 3793 doi: 10.1007/s13277-013-1502-8
|
19 |
A. Pryczynicz, M. Gryko, V. Dymicka-Piekarska, Ł Lewczuk, A. Wakulewska, M. Ozimkiewicz, A. Lebelt, K. Guzińska-Ustymowicz. Clinical usefulness of MMP-2 and TIMP-2 concentrations in the preoperative serum of patients with colorectal cancer. Progress in Health Sciences 2016; 6(1): 32 doi: 10.5604/01.3001.0009.5107
|
20 |
Marta Łukaszewicz-Zając, Barbara Mroczko, Maciej Szmitkowski. Gastric cancer — The role of matrix metalloproteinases in tumor progression. Clinica Chimica Acta 2011; 412(19-20): 1725 doi: 10.1016/j.cca.2011.06.003
|
21 |
Hilal Gungor, Nevin Ilhan, Hatice Eroksuz. The effectiveness of cyclooxygenase-2 inhibitors and evaluation of angiogenesis in the model of experimental colorectal cancer. Biomedicine & Pharmacotherapy 2018; 102: 221 doi: 10.1016/j.biopha.2018.03.066
|
22 |
Imelda Juárez-Avelar, Tonathiu Rodríguez, Ana P. García-García, Miriam Rodríguez-Sosa. Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives. 2021; : 173 doi: 10.1016/B978-0-12-822028-3.00012-1
|
23 |
Marta Łukaszewicz-Zając, Barbara Mroczko. Circulating Biomarkers of Colorectal Cancer (CRC)—Their Utility in Diagnosis and Prognosis. Journal of Clinical Medicine 2021; 10(11): 2391 doi: 10.3390/jcm10112391
|
24 |
Timothy G. K. Mant, Daniel Bradford, Dipti M. Amin, Jaya Pisupati, Yoshikazu Kambayashi, Yoshitaka Yano, Kazushige Tanaka, Takuko Yamada‐Sawada. Pharmacokinetics and safety assessments of high‐dose and 4‐week treatment with S‐3304, a novel matrix metalloproteinase inhibitor, in healthy volunteers. British Journal of Clinical Pharmacology 2007; 63(5): 512 doi: 10.1111/j.1365-2125.2006.02794.x
|
25 |
Kyung Sook Park, Seon Jeong Kim, Kyung Ho Kim, Jin Cheon Kim. Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer. Journal of Gastroenterology and Hepatology 2011; 26(2): 391 doi: 10.1111/j.1440-1746.2010.06504.x
|
26 |
Gao-Chao Fan, Li Han, Hua Zhu, Jian-Rong Zhang, Jun-Jie Zhu. Ultrasensitive Photoelectrochemical Immunoassay for Matrix Metalloproteinase-2 Detection Based on CdS:Mn/CdTe Cosensitized TiO2 Nanotubes and Signal Amplification of SiO2@Ab2 Conjugates. Analytical Chemistry 2014; 86(24): 12398 doi: 10.1021/ac504027d
|
27 |
Tae-Dong Kim, Kyoung-Sub Song, Ge Li, Hoon Choi, Hae-Duck Park, Kyu Lim, Byung-Doo Hwang, Wan-Hee Yoon. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer. BMC Cancer 2006; 6(1) doi: 10.1186/1471-2407-6-211
|
28 |
Hui-Jing Pan, Qing-Yun Zhou, Ying-Chao Gong, Li-Ping Jia, Wei Zhang, Lei Shang, Qing-Wang Xue, Qin Wei, Huai-Sheng Wang, Rong-Na Ma. A universal distance-independent ratiometric electrochemical biosensing strategy based on competitive host-guest interactions for matrix metalloproteinase-2 detection. Sensors and Actuators B: Chemical 2023; 378: 133144 doi: 10.1016/j.snb.2022.133144
|
29 |
O. Schwandner, A. Schlamp, R. Broll, H. P. Bruch. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer. International Journal of Colorectal Disease 2006; 22(2): 127 doi: 10.1007/s00384-006-0173-y
|
30 |
John Maringa Githaka, Leila Pirayeshfard, Ing Swie Goping. Cancer invasion and metastasis: Insights from murine pubertal mammary gland morphogenesis. Biochimica et Biophysica Acta (BBA) - General Subjects 2023; 1867(8): 130375 doi: 10.1016/j.bbagen.2023.130375
|
31 |
Catalina Cioates Negut, Ruxandra-Maria Ilie-Mihai, Raluca-Ioana Stefan-van Staden. Determination of Matrix Metalloproteinase 2 in Biological Samples Using a 3D Stochastic Microsensor Based on Graphene Oxide/AuNanoparticles/(Z)-N-(pyridin-4-yl-methyl) Octadec-9-enamide. International Journal of Molecular Sciences 2024; 25(12): 6720 doi: 10.3390/ijms25126720
|
32 |
Z. Cavdar, A. E. Canda, C. Terzi, S. Sarioglu, M. Fuzun, G. Oktay. Role of gelatinases (matrix metalloproteinases 2 and 9), vascular endothelial growth factor and endostatin on clinicopathological behaviour of rectal cancer. Colorectal Disease 2011; 13(2): 154 doi: 10.1111/j.1463-1318.2009.02105.x
|
33 |
Lars Frich, Kristin Bjørnland, Solveig Pettersen, Ole Petter F. Clausen, Ivar P. Gladhaug. Increased Activity of Matrix Metalloproteinase 2 and 9 After Hepatic Radiofrequency Ablation. Journal of Surgical Research 2006; 135(2): 297 doi: 10.1016/j.jss.2006.05.010
|
34 |
Dipshikha Bajracharya, Bijayatha Shrestha, Asha Kamath, Aparna Menon, Raghu Radhakrishnan. Immunohistochemical Correlation of Matrix Metalloproteinase-2 and Tissue Inhibitors of Metalloproteinase-2 in Tobacco Associated Epithelial Dysplasia. Disease Markers 2014; 2014: 1 doi: 10.1155/2014/197813
|